CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Published:2021-10 Issue:10 Volume:8 Page:e711-e722
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Leahy Allison Barz,Newman Haley,Li Yimei,Liu Hongyan,Myers Regina,DiNofia Amanda,Dolan Joseph G,Callahan Colleen,Baniewicz Diane,Devine Kaitlin,Wray Lisa,Aplenc Richard,June Carl H,Grupp Stephan A,Rheingold Susan R,Maude Shannon L

Funder

Children's Hospital of Philadelphia

University of Pennsylvania

National Institutes of Health

Novartis Pharmaceuticals Corporation

Pfizer

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

2. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;New Engl J Med,2014

3. Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia;Maude;New Engl J Med,2018

4. Intent-to-treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017

5. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study;Sun;Leukemia,2018

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study;Pharmaceuticals;2024-08-05

2. Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what’s next?;Leukemia & Lymphoma;2024-06-11

3. Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia;Haematologica;2024-05-10

4. Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives;Frontiers in Immunology;2024-03-15

5. The Implementation of Chimeric Antigen Receptor (CAR) T-cell Therapy in Pediatric Patients: Where Did We Come From, Where Are We Now, and Where are We Going?;Clinical Hematology International;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3